NRXPW vs PODD · rev $242.0K vs P/E 34, rev $1.56B
NRx Pharmaceuticals Inc (NRXPW) versus Insulet Corporation (PODD) — a side-by-side from cached financials, not a winner call.
NRx Pharmaceuticals Inc (NRXPW) common stock listed on NASDAQ.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Latest reported NRXPW revenue for 2025-09-30 was $242.0K. Net income was -$5.9M. NRXPW currently screens at market cap $714.6M.
Latest reported PODD revenue for 2026-06-30 was $1.56B. Net income was $186.1M. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
NRXPW currently screens at market cap $714.6M. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Not investment advice. Open the NRXPW and PODD stock pages for the full models.
Not investment advice.